What's new

Questions and answers on the outcome of assessment on use of Revolade in treatment of severe aplastic anaemia in children

Questions and answers on the outcome of assessment on use of Revolade in treatment of severe aplastic anaemia in children

Jun 27, 2025 - 11:10
 0
Questions and answers on the outcome of assessment on use of Revolade in treatment of severe aplastic anaemia in children
Read More

Tags:

Previous Article

Mechanical ventilator - Notified body 2696 - 10/01/2025 - Expert decision and op...

Next Article

Greek energy group Metlen plans August London listing

Related Posts

Human medicines European public assessment report (EPAR): Uplizna, inebilizumab, Date of authorisation: 25/04/2022, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR...

May 15, 2025  0

Antimicrobial Sales and Use (ASU) Platform: Release notes

Jun 18, 2025  0

Management Board meeting dates 2026-2027

Jun 20, 2025  0